Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study.
Takahashi K, Ohji M, Terasaki H, Honda S, Margaron P, Guerin T, Yuzawa M. Takahashi K, et al. Among authors: ohji m. Clin Ophthalmol. 2018 Sep 13;12:1789-1799. doi: 10.2147/OPTH.S171015. eCollection 2018. Clin Ophthalmol. 2018. PMID: 30271112 Free PMC article.
Photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD): results of the Japanese AMD Trial (JAT) extension.
Japanese Age-Related Macular Degeneration Trial (JAT) Study Group; Ohji M. Japanese Age-Related Macular Degeneration Trial (JAT) Study Group, et al. Among authors: ohji m. Jpn J Ophthalmol. 2008 Mar-Apr;52(2):99-107. doi: 10.1007/s10384-008-0512-3. Epub 2008 Apr 30. Jpn J Ophthalmol. 2008. PMID: 18626732 Clinical Trial.
292 results